FACIT congratulates its strategic partner, OICR, on its leading role in completing an unprecedented, multi-institutional study of whole cancer genomes, spanning 10 years.
The output from this global study vastly improves the fundamental understanding of cancer and will provide guidance and new directions for its diagnosis and treatment.
Annual cancer-focused competition showcases Ontario’s emerging entrepreneurs and FACIT’s commitment to drive local value from intellectual property
The winning pitch was delivered by Mr. Meir Dick of Bridge7 Oncology. This local start-up is scaling clinical expertise with AI to automate and improve the efficiency, consistency and quality of delivering cancer care.
